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Monday, February 27, 2012 353amyocytes (MCT 0.085 0.01 mm vs CON 0.045 0.01 mm, P < 0.001). MCT
n = 25 cells; CON n = 18 cells, 2 way RM ANOVA.
We conclude that the shorter resting SL in MCT myocytes is due to the forma-
tion of Ca2þ-independent cross-bridges, we speculate that these are formed in
response to disturbances in cellular metabolism, by mechanisms currently un-
der investigation.
Supported by the BHF and MRC
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Adult cardiac muscle adapts to changes in the environment by growth and
remodeling via a variety of mechanisms. Hypertrophy develops when the
heart is subjected to chronic mechanical overload. In ventricular pressure
overload (due to aortic stenosis) the heart typically reacts by concentric hy-
pertrophic growth, characterized by wall thickening due to myocyte thicken-
ing when sarcomeres are added in parallel. In ventricular volume overload,
an increase in filling pressure (due to mitral regurgitation) leads to eccentric
hypertrophy as myocytes grow axially by adding sarcomeres in series lead-
ing to ventricular cavity enlargement that is typically accompanied by some
wall thickening. The specific biomechanical stimuli that stimulate different
modes of hypertrophy are still poorly understood. Recently, we proposed
that cardiac myocytes grow longitudinally to maintain a preferred sarcomere
length in response to increased fiber strain and axially to maintain interfila-
ment lattice spacing in response to increased crossfiber strain. Here, we test
whether this growth law is able to predict concentric and eccentric hypertro-
phy in response to aortic stenosis and mitral valve regurgitation, respec-
tively, in a computational model of the adult canine heart coupled to
a closed loop model of circulatory hemodynamics. A finite element model
of the beating canine ventricles coupled to the circulation that was used. Af-
ter inducing valve alterations, the ventricles were allowed to adapt in shape
in response to mechanical stimuli over time. The proposed growth law was
able to reproduce major acute and chronic physiological responses when in-
tegrated with comprehensive models of the pressure- and volume-overloaded
canine heart, coupled to a closed-loop circulation. We conclude that strain-
based biomechanical stimuli consistent with in-vitro studies of myocyte
stretch responses can drive cardiac growth, including wall thickening during
pressure overload.
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Background: Hypertrophic cardiomyopathy (HCM) is frequently caused by
mutations in genes encoding sarcomeric proteins. Previously, we observed a re-
duced maximal force generating capacity (Fmax) of cardiomyocytes from
HCM patients with mutations in myosin-binding protein-C (MYBPC3). In
this study we investigated the contribution of myofibril density (MyoD) and
cross-sectional area (CSA) to the reduction in Fmax.
Methods: We measured Fmax and CSA of single permeabilized ventricular
cardiomyocytes of 27 HCM patients with mutations in MYBPC3, myosin
heavy chain: MYH7, troponin T: TNNT2 and troponin I: TNNI3 and 10
non-failing donor hearts. MyoD was calculated as the sum of myofibril area re-
lated to cell area assessed by electron microscopy.
Results: Average Fmax was significantly lower in HCM groups compared to
donor (Figure A). Figure B shows that MyoD of HCM hearts was reduced com-
pared to donors. CSA of HCM hearts (529548mm2) was significantly higher
compared to donors (342512mm2). Linear regression analysis revealed a
significant negative linear relationship between CSA and Fmax (R2= 0.50,
b=-0.023, p=0.014).Conclusion: Cardio-
myocyte hypertro-
phy and reduced
myofibrillar density
underlie depressed
Fmax in HCM with
mutations in thick
and thin sarcomeric
proteins.
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SPontaneous Oscillatory Contraction (SPOC) is a physiological state induced
in striated muscle fibres under conditions of partial activation. SPOC is charac-
terised by repetitive auto-oscillations between cycles of rapid lengthening and
slow shortening that correlate with diastole and systole respectively. We acti-
vate cardiomyocytes using ADP-induced SPOC and Ca2þ induced SPOC.
Ca-SPOC correlates well with heart rate observed in a number of animal
models.
The current study quantifies contractile performance of cardiomyocytes iso-
lated from human dilated and hypertrophic cardiomyopathies (some with
known mutations) and compares them with age-matched non-failing donors.
Measured parameters of contractile performance include the velocity, period
and amplitude of contraction, relaxation and SPOC-wave. We compare
changes in contractile performance between (1) failing and non-failing hearts,
(2) hearts from a wide range of donor ages, and (3) differences between ADP-
and Ca-SPOC. These observations are then related to patient clinical data (e.g.
ejection fraction).
Interestingly, human heart samples flash frozen (200C) within minutes of the
loss of coronary blood flow can be re-activated even after up to 20 years of stor-
age. Cardiac muscle fibres from the left atria and left ventricles, interventricular
septa and papillary muscles were specially defrosted prior to microdissection.
Length changes were measured using a Leica SP5 multi-photon microscope
and then averaged at high spatial and temporal resolution.
Preliminary data identify measureable changes in contractile performance be-
tween non-failing and failing hearts. Samples of hypertrophic cardiomyopathy
exhibit decreased rates of relaxation consistent with their clinical diagnosis.
These observations reveal SPOC to yield a range of functional parameters
that can be used to evaluate the functional state of human heart muscle fibres.
Thus, SPOC may prove to be a valuable measurement that can objectively as-
sess the state of human heart failure.
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It is generally believed that the rhythmof heartbeat is controlled by electric stim-
ulations produced by pacemaker cells. However, sarcomeres in cardiac myofi-
brils exhibit spontaneous rhythmic oscillations of sarcomere length (SL) and
force under partial activation conditions (i.e., SPOC). SPOC occurs either at
pCa~6.0 (Ca-SPOC ) or at the coexistence of MgADP and Pi in the absence of
Ca2þ (ADP-SPOC) (Ishiwata et al., 2011). We have reported that the SPOC pe-
riod correlates strongly with the resting heart rate in various animal species
(Sasaki et al., 2006). In the present study, to test whether SPOC plays a key
role in the regulation of heartbeat, we performed analyses on thewaveformprop-
erties of SPOC by using rat neonatal cardiomyocytes expressing AcGFP in the
Z-lines. First, we found that SPOC occurs in the neonatal myocytes treated
with ionomycin at pCa ~6.0 (pCa adjusted by Ca/EGTA), viz., in the presence
354a Monday, February 27, 2012of the inner-membrane system.We termed this phenomenon ‘‘Cell-SPOC’’.Our
careful analysis revealed that the shortening time depends strongly on the ampli-
tude during Cell-SPOC, whereas the dependence was relatively weak for the
lengthening time. Next, we electrically activated the intact, untreated myocytes
at various frequencies (1 - 5Hz) in Tyrode’s solution containing 2mMCa2þ, and
compared the waveform properties of SL oscillations to those obtained during
Cell-SPOC.We found that thewaveformproperties at physiologically high elec-
tric frequencies (4 - 5Hz)were statistically indistinguishable from those obtained
during Cell-SPOC occurring at the similar frequencies. These findings support
the notion that SPOC plays a key role in propagating the rhythm of shorten-
ing/relengthening to adjacent sarcomeres along myofibrils, thereby producing
efficient, periodic contractions of cardiac muscle in vivo.
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At birth, the heart is challenged with a shift from relative hypoxia to normoxia
and from lower hemodynamic load on the ventricles to higher load, due to dif-
ferences between in utero and ex utero oxygen tension and fetal and newborn
blood circulation. Evidence suggests that postnatal cardiac hypertrophy may be
regulated in part by these changes in hemodynamic loading and oxygen supply
to the newborn heart. Here we test the hypothesis that mechanical overload and
the shift from hypoxic to normoxic conditions may be signals that regulate neo-
natal myocyte maturation and growth. NMVMs were cultured on PDMS mem-
branes subjected to 5% equibiaxial stretch for 15 minutes to 4 hours, under both
normoxic (5% CO2 in air) and hypoxic (6.8 % CO2 with 5 % O2) conditions,
after which we measured protein expression by Western blotting. Under nor-
moxic conditions, whole cell lysates from control membranes (without stretch)
were negative for atrial natriuretic factor (ANF) protein expression as evi-
denced by immunoblotting. In contrast, by one hour of mechanical overload,
lysates immunoblotted for ANF showed a nearly 2 -fold increase in ANF pro-
tein expression which returned to near baseline levels within 4 hours of me-
chanical stretch. Conversely, myosin heavy chain (MHC) protein expression
was detected in lysates from cardiomyocytes subjected to 15 mins mechanical
stretch and increased monotonically as evidenced by a 4-fold increase in pro-
tein expression by 4 hours of stretch. Furthermore, connexin-43 protein expres-
sion increased almost 3-fold over the unstretched controls after 15 mins of
stretch. Preliminary data indicates that compared to normoxic conditions, ex-
pression of these signaling proteins decreases under hypoxic conditions. An un-
derstanding of the role of mechanical stretch in cardiomyocytes cultured under
hypoxic conditions holds promise for advancing cardiac regenerative medicine.
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Dilated cardiomyopathy (DCM) is a progressive disease often associated with
heart failure (HF) and sudden death (SD). We have been studying cause and
mechanism of SD/lethal arrhythmia in DCM using a mouse model with a muta-
tion in cardiac troponin T (DK210), which displays cardiac dilation and shows
frequent death with t1/2 of ~70 days. In experiments with such mouse models
with progressive heart diseases, it is necessary to assess severity of HF in living
mice. To do so we measured voluntary exercise using a running wheel (r=6cm).
Wheel-running activity was basically similar betweenwild type (WT) andDCM
mice (17.155.7 vs 17.556.9 x 103 rounds/day (rpd)) until 2 months old. After
then, however, some DCMmice died suddenly while keeping their running ac-
tivity and others started to lose running activity and died. DCM mice were di-
vided into two groups; mice with normal (>15000 rpd) and decreased running
activity (<2000 rpd), and heart weight/body weight ratio (HW/BW) and lung
weight/body weight ratio (LW/BW) were determined as indicatives of cardiac
dilation and congestive HF, respectively. There was a significant negative corre-
lation between running activity and LW/BW ratio, indicating that runningwheel
is a useful for detecting congestive HF in mouse model. These results suggest
that some of the DCM mice die suddenly without HF, probably with lethal ar-
rhythmia, whereas others develop severe HF and die. We carried out real-time
PCR analysis for BNP and ion channels in two groups. The difference and sim-
ilarity in expression levels of ion channels between two groupswill be discussed.1797-Pos Board B567
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Ischemia produces a reduction in vascular tone and the sensitivity toNOmediated
vasodilatation of the ischemic vascular bed. However, whether cardiac ischemia
has any deleterious effect on the contractile properties of nonischemic, peripheral
vascular beds is unknown. Thus, the aim of the current study was to determine
whether acute myocardial ischemia results in peripheral vascular dysfunction.
We determined force and the sensitivity to ACh mediated smooth muscle relax-
ation of tertiary (3rd) mesenteric arteries of rats following 30 min of myocardial
ischemia (ischemia) compared to sham (perfused). During KCl depolarization,
myocardial ischemia did not affect peak force, but significantly depressed force
maintenance. For perfused vessels,KCl depolarization resulted in a significant in-
crease in both smooth muscle (SM) and nonmuscle (NM) light chain (LC) phos-
phorylation. However, in ischemic vessels, there was not only a decrease in the
expression of the LCs, but also SM-LC phosphorylation was depressed whilst
there was no detectable NM-LC phosphorylation. Compared to perfused vessels,
there was a decrease in the relaxation in response to both ACh and 8-Br-cGMP in
ischemic 3rdmesenteric arteries, and in the expression ofMYPT1. Further, ische-
mia was associated with an increase in protein poly-ubiquitination, suggesting
that during ischemia both the LCs and MYPT1 are targeted for degradation by
the proteasome. These results suggest that NMmyosin contributes to the contrac-
tile properties of 3rd mesenteric vessels, and ischemia inhibits NMmyosin to de-
press vascular tone. Additionally, ischemia results in a decrease in MYPT1
expression, which contributes to the decrease in the sensitivity to NO mediated
vasodilatation. In conclusion, acute myocardial ischemia alters the peripheral
vascular phenotype, which contributes to the decrease in both force maintenance
and the sensitivity to NO mediated smooth muscle relaxation.
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Myosins play a crucial role for a wide range of physiological functions. The dys-
function or absence of myosinmotors has been linked to diseases such asmuscle
wasting, heart failure, blood disorders, severe forms of senso-neuronal degener-
ation and cancer. Therefore, the development of selective and potent small-
molecule myosin effectors holds the promise to open routes for the treatment
of a wide range of disabling diseases. In this study, we show that the thiadiazi-
none derivative EMD57033 acts as a pharmacological chaperone for several
members of the myosin family. Our results show that EMD57033 stimulates
the actin-activated ATPase activity and motor activity of myosins from classes
2,5 and 6 up to 3-fold. The most potent interaction was observed with cardiac b-
myosin. EMD57033 lowers the apparent second binding constant for F-actin
binding in the presence of ATP from 31 mM (þ/- 6 mM) to 4 mM (þ/- 1 mM).
The KM value for ATP remains unaffected by the drug. Furthermore, addition
of 10 mM EMD57033 rescues the motor function of ‘‘aged’’ cardiac b-myosin
preparations that display strongly reduced activity in the in vitro motility assay
prior to addition of the drug. Structural studies indicate that EMD57033 binds in
a pocket that is located between theN-terminal SH3-like subdomain and themo-
tor domain-lever arm junction. The participation of the N-terminal SH3-like
subdomain in EMD57033 binding is supported by the failure of class-1myosins,
which lack this domain, to productively interact with EMD57033.
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Spatiotemporal cardiac gene targeting featuring a-MyHC-MerCreMer (MCM)
transgenic mice is an important approach for studying heart-specific gene func-
tion. The modified estrogen receptor (MER) is activated by the selective estro-
gen receptor modulator (SERM) tamoxifen. MER activation by tamoxifen
results in nuclear translocation of MCM, and Cre-mediated excision of loxP-
flanked genes. A drawback to tamoxifen-dependent Cre translocation is tran-
sient cardiomyopathy, which is suggested to be independent of gene excision
and dependent on the presence of MCM. However, studies using isolated car-
diac myocytes reveal the presence of an acute non-genomic inhibitory effect of
tamoxifen on several types of ion channels, suggesting tamoxifen also may
have an effect in the absence of MCM. The goal of the present study was to
determine whether the inhibition of ion channels found in previous studies
